The purpose of the Apremilast Pregnancy Exposure Registry is to monitor planned and unplanned
pregnancies exposed to apremilast and to evaluate the safety of this medication relative to
specified pregnancy outcomes, and to evaluate potential effects of prenatal apremilast
exposure on infant health status through one year of age.
Details
Lead Sponsor:
University of California, San Diego
Collaborators:
Celgene The Organization of Teratology Information Specialists